What a Bright SPARC!

news July 13 2017

Exalpha manufacture and supply a comprehensive range of high quality antibodies that have been raised against a synthetic peptide derived from human SPARC protein. The polyclonal antibodies are suitable for western blotting, ELISA and immunohistology applications and have been fully validated in Western blotting against whole cell lysate. A blocking peptide is also available for use with polyclonal antibodies X1860P & X1867P.

X1855B – SPARC, Blocking Peptide
X1860P – SPARC, Polyclonal Antibody
X1867P – SPARC, Affinity Purified Polyclonal antibody
X2745P – SPARC, Biotin conjugated Affinity Purified Polyclonal antibody
X2546M – SPARC, Monoclonal Antibody (suitable for paraffin sections)
IHC – Detection of endogenouse SPARC in human hepatocellular carinoma (HCC).
2ug/ml x 1867P, developed with Vector ImmPress anti-rabbit HRP and DAB substrate.
 
Highlights 
• The polyclonal antibodies X1867P & X2745P are antigen affinity purified and therefore highly purified products.
• Blocking peptide for use with these antibodies are available. 
• The monoclonal antibody X2546M is suitable for paraffin sections.
• Finally the antibodies have been fully validated in WB against whole cell lysate (mouse heart lysate).
 
 

Subscribe to our newsletter

Get the latest news within your area of research to your inbox.
Subscribe →